Diagnostic Workup for Simultaneous Hematospermia and Hematuria
When a patient presents with both blood in semen and blood in urine together, this represents symptomatic hematospermia requiring comprehensive imaging evaluation, with MRI pelvis (with or without contrast) as the preferred initial imaging modality, combined with urinalysis, urine culture, and cystoscopy to exclude malignancy and identify treatable causes.
Initial Clinical Assessment
The combination of hematospermia with hematuria is clinically significant and warrants thorough investigation, as this presentation suggests pathology affecting both the urinary and reproductive tracts 1. This differs from isolated hematospermia, which is typically benign and often requires only reassurance.
Key Historical Elements to Obtain:
- Age (malignancy risk increases significantly >40 years, particularly >35 years for hematuria) 2, 3
- Smoking history and occupational chemical exposures 2
- Associated symptoms: fever, pain, dysuria, irritative voiding symptoms 1
- History of trauma to the pelvis or genitourinary tract 1
- Prior urologic disease, pelvic irradiation, or chronic UTIs 2
- Timing: Does hematuria occur specifically after ejaculation or erection? 4
Essential Laboratory Workup:
- Urinalysis with microscopy (properly collected, non-contaminated specimen) 2
- Urine culture before initiating antibiotics if infection suspected 2
- Prostate-specific antigen (PSA) - significantly elevated in hematospermia with epididymitis 5
- Serum creatinine to assess renal function 2
Imaging Strategy
Primary Imaging Recommendation
MRI pelvis without and with IV contrast is the most appropriate initial imaging study for this presentation 1. This modality provides:
- Superior soft tissue resolution for visualizing seminal vesicles, prostate, and ejaculatory ducts
- Detection of seminal vesicle hemorrhage (found in 86.2% of patients with recurrent hematospermia) 1
- Identification of masses, cysts, abscesses, and vascular anomalies
- Evaluation of prostate pathology including cancer
Alternative if MRI unavailable or contraindicated: CT urography (CTU) without and with IV contrast provides comprehensive evaluation of both upper and lower urinary tracts plus pelvic organs, though with inferior soft tissue detail compared to MRI 1, 2.
Rationale for Imaging Choice
The 2025 ACR Appropriateness Criteria specifically state that when hematospermia presents with associated hematuria, imaging is useful in confirming possible pathologies including urinary tract stones, masses, prostatic abscess, and congenital anomalies 1. MRI's superior tissue characterization makes it ideal for detecting:
- Seminal vesicle pathology (hemorrhage, cysts, calculi)
- Prostatic lesions requiring multiparametric evaluation
- Ejaculatory duct obstruction
- Vascular malformations
- Blood products (readily visible even without contrast) 1
Secondary Imaging Considerations
Transrectal ultrasound (TRUS) can be considered as an adjunct, particularly for:
- Guiding seminal vesicle aspiration to confirm bleeding source 6
- Evaluating seminal vesicle cysts and calculi
- Directing prostate biopsy if indicated 1
However, TRUS has limited field of view and is less commonly used as initial imaging in the United States 1.
Cystoscopy
Cystoscopy is mandatory in this clinical scenario 2. The presence of hematuria, particularly when combined with hematospermia, requires direct visualization to exclude:
- Bladder malignancy (gross hematuria has 30-40% association with malignancy) 2
- Posterior urethral hemangioma (a frequently missed cause of combined hematospermia and post-ejaculation hematuria) 4
- Ectopic prostatic tissue in the prostatic urethra 6
- Prostatic urethral lesions
Critical Technical Point for Cystoscopy
Perform cystoscopy immediately after ejaculation or erection when possible, with reduced irrigant flow, to enhance detection of posterior urethral hemangiomas - a commonly overlooked cause of this presentation 4. These lesions typically appear as 5mm solitary sessile varicosities on the membranous urethra between the verumontanum and external sphincter.
Age-Stratified Approach
Patients ≥40 Years Old:
- Full workup mandatory due to 7.2% prostate cancer detection rate in hematospermia patients this age 3
- PSA testing essential
- Consider multiparametric MRI with dedicated prostate protocol if PSA elevated or clinical suspicion 1
- Cystoscopy non-negotiable given malignancy risk
Patients <40 Years Old:
- Still requires imaging and cystoscopy given symptomatic presentation with hematuria
- Cancer risk lower (0.01% in isolated hematospermia) but not zero 7
- Focus on infectious, inflammatory, and vascular etiologies
Common Pitfalls to Avoid
Do not dismiss as benign isolated hematospermia - the presence of concomitant hematuria changes risk stratification entirely 1
Do not delay workup for anticoagulation - anticoagulant use does not alter the need for evaluation 2
Do not miss posterior urethral hemangioma - this requires specific cystoscopic technique (post-ejaculation timing, reduced flow) and is more common than historically recognized 4
Do not skip imaging in favor of observation - symptomatic hematospermia with hematuria warrants imaging regardless of age 1
Do not obtain CT without urographic protocol - if choosing CT over MRI, ensure proper CTU technique with non-contrast, nephrographic, and excretory phases 2
Special Consideration: Arterial Bleeding
In cases of intractable hematospermia with persistent hematuria unresponsive to treatment, consider pelvic angiography 8. Arterial bleeding (typically from internal pudendal artery) can be detected and treated with transcatheter arterial embolization without causing impotence, though long-term follow-up is needed for potential recurrence from contralateral flow 8.
Infectious Workup
If clinical features suggest infection (fever, leukocytosis, scrotal pain):
- Obtain urine culture before antibiotics 2
- Consider testing for sexually transmitted infections including Chlamydia trachomatis and Escherichia coli 5
- Note that hematospermia may precede scrotal symptoms of epididymitis by 24 hours 5
- Follow-up semen analysis at 14 days may still show hematospermia with leukocytospermia 5